Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR mee

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 will be presented in a poster presentation at the American Association for Cancer Research Annual Meeting in Washington, DC.

More... (http://www.news-medical.net/news/20130123/Data-from-Provectus-PV-10-pre-clinical-study-on-melanoma-to-be-presented-at-AACR-meeting.aspx)